Tower Research Capital (TRC)’s Legend Biotech LEGN Stock Holding History
Bought
Maintained
Sold
Other funds holding LEGN
KCM
Tower Research Capital (TRC)'s LEGN Position: Q3 2026 in Review
Tower Research Capital (TRC) increased its Legend Biotech (LEGN) stake by 2,100% in Q3 2026, buying an estimated $280K and bringing the position to 13,769 shares worth $274K. The position accounts for ﹤0.01% of the portfolio, ranked #2153.
Tower Research Capital (TRC) first reported a position in LEGN in Q3 2020 and has held it in 25 quarters since. The position peaked at $979K in Q2 2023. 198 funds tracked by Wall St. Rank hold LEGN as of Q3 2026.
- Tower Research Capital (TRC) held 13,769 shares of Legend Biotech worth $274K as of Q3 2026.
- Tower Research Capital (TRC) bought 13,143 Legend Biotech shares in Q3 2026, an estimated $280K.
- Legend Biotech made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #2153 holding.
- Tower Research Capital (TRC) first reported a position in Legend Biotech in Q3 2020 and has held it in 25 quarters since.
- Tower Research Capital (TRC)'s Legend Biotech position peaked at $979K in Q2 2023.
- 198 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.